Doron Lipson
Doron Lipson
VP, Product Development, Foundation Medicine
Bestätigte E-Mail-Adresse bei foundationmedicine.com
Titel
Zitiert von
Zitiert von
Jahr
GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists
E Eden, R Navon, I Steinfeld, D Lipson, Z Yakhini
BMC bioinformatics 10 (1), 1-7, 2009
27092009
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
GM Frampton, A Fichtenholtz, GA Otto, K Wang, SR Downing, J He, ...
Nature biotechnology 31 (11), 1023-1031, 2013
14582013
Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies
D Lipson, M Capelletti, R Yelensky, G Otto, A Parker, M Jarosz, JA Curran, ...
Nature medicine 18 (3), 382-384, 2012
8482012
Two-state allosteric behavior in a single-domain signaling protein
BF Volkman, D Lipson, DE Wemmer, D Kern
Science 291 (5512), 2429-2433, 2001
7092001
Discovering motifs in ranked lists of DNA sequences
E Eden, D Lipson, S Yogev, Z Yakhini
PLoS Comput Biol 3 (3), e39, 2007
6352007
Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab
DR Gandara, SM Paul, M Kowanetz, E Schleifman, W Zou, Y Li, ...
Nature medicine 24 (9), 1441-1448, 2018
4862018
Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer
A Vaishnavi, M Capelletti, AT Le, S Kako, M Butaney, D Ercan, S Mahale, ...
Nature medicine 19 (11), 1469-1472, 2013
4692013
Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors
GM Frampton, SM Ali, M Rosenzweig, J Chmielecki, X Lu, TM Bauer, ...
Cancer discovery 5 (8), 850-859, 2015
4682015
Response to Cabozantinib in patients with RET fusion-positive lung adenocarcinomas
A Drilon, L Wang, A Hasanovic, Y Suehara, D Lipson, P Stephens, J Ross, ...
Cancer discovery 3 (6), 630-635, 2013
4622013
Emergence of constitutively active estrogen receptor-α mutations in pretreated advanced estrogen receptor–positive breast cancer
R Jeselsohn, R Yelensky, G Buchwalter, G Frampton, F Meric-Bernstam, ...
Clinical cancer research 20 (7), 1757-1767, 2014
4512014
Comparative genomic hybridization using oligonucleotide microarrays and total genomic DNA
MT Barrett, A Scheffer, A Ben-Dor, N Sampas, D Lipson, R Kincaid, ...
Proceedings of the National Academy of Sciences 101 (51), 17765-17770, 2004
4272004
Aberrant overexpression of satellite repeats in pancreatic and other epithelial cancers
DT Ting, D Lipson, S Paul, BW Brannigan, S Akhavanfard, EJ Coffman, ...
science 331 (6017), 593-596, 2011
4222011
Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneity
H Beltran, R Yelensky, GM Frampton, K Park, SR Downing, ...
European urology 63 (5), 920-926, 2013
4062013
Kinase fusions are frequent in Spitz tumours and spitzoid melanomas
T Wiesner, J He, R Yelensky, R Esteve-Puig, T Botton, I Yeh, D Lipson, ...
Nature communications 5 (1), 1-9, 2014
4022014
New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencing
JS Ross, K Wang, L Gay, R Al-Rohil, JV Rand, DM Jones, HJ Lee, ...
The oncologist 19 (3), 235, 2014
3122014
Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions
CM Lovly, A Gupta, D Lipson, G Otto, T Brennan, CT Chung, ...
Cancer discovery 4 (8), 889-895, 2014
2372014
Quantification of the yeast transcriptome by single-molecule sequencing
D Lipson, T Raz, A Kieu, DR Jones, E Giladi, E Thayer, JF Thompson, ...
Nature biotechnology 27 (7), 652-658, 2009
2292009
Methods for detecting fetal nucleic acids and diagnosing fetal abnormalities
S Lapidus, JF Thompson, D Lipson, P Milos, JW Efcavitch, S Letovsky
US Patent App. 12/727,824, 2010
2022010
Genomic and functional analysis of leukemic transformation of myeloproliferative neoplasms
R Rampal, J Ahn, O Abdel-Wahab, M Nahas, K Wang, D Lipson, GA Otto, ...
Proceedings of the National Academy of Sciences 111 (50), E5401-E5410, 2014
2002014
Broad, hybrid capture–based next-generation sequencing identifies actionable genomic alterations in lung adenocarcinomas otherwise negative for such alterations by other …
A Drilon, L Wang, ME Arcila, S Balasubramanian, JR Greenbowe, ...
Clinical cancer research 21 (16), 3631-3639, 2015
1912015
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20